By Stephen NakrosisNovavax said the European Commission approved its updated Covid-19 vaccine for use in the European Union for individuals age 12 and above. The approval of NVX-CoV2601 follows a positive opinion for approval from the Committee for Medicinal Products for Human Use of the European Medicines Agency, Novavax said.

Source: Wall Street Journal October 31, 2023 21:00 UTC